Approval · Notice of Compliance 19442 · 2017
MINT-FENOFIBRATE E: Notice of Compliance 19442
Issued June 21, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19442
- Date
- June 21, 2017
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- LIPIDIL EZ (Fournier Pharma Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-FENOFIBRATE E | 02465167 | Cancelled Post Market |
Medicinal ingredients
- FENOFIBRATE 145 MG per TAB